Connection

Michael Gold to Atrial Fibrillation

Back to Details
This is a "connection" page, showing publications Michael Gold has written about Atrial Fibrillation.
Michael Gold
Connection Strength
7.748
Atrial Fibrillation
  1. Same-day discharge after catheter ablation in patients with atrial fibrillation in a large nationwide administrative claims database. J Cardiovasc Electrophysiol. 2021 09; 32(9):2432-2440.
    View in: PubMed
    Score: 0.609
  2. Prophylactic pulmonary vein isolation during cavotricuspid isthmus ablation for atrial flutter: A meta-analysis. Pacing Clin Electrophysiol. 2019 05; 42(5):493-498.
    View in: PubMed
    Score: 0.517
  3. Response by Gold to Letter Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?" Circulation. 2018 07 03; 138(1):124.
    View in: PubMed
    Score: 0.492
  4. Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two? Circulation. 2018 01 16; 137(3):217-218.
    View in: PubMed
    Score: 0.476
  5. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion. J Cardiovasc Transl Res. 2013 Aug; 6(4):528-35.
    View in: PubMed
    Score: 0.346
  6. Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
    View in: PubMed
    Score: 0.267
  7. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm. 2009 Mar; 6(3):295-301.
    View in: PubMed
    Score: 0.253
  8. Atrial overdrive pacing and incidence of heart failure-related adverse events in permanently paced patients. J Interv Card Electrophysiol. 2007 Jun; 19(1):55-60.
    View in: PubMed
    Score: 0.229
  9. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI). Am Heart J. 2006 Aug; 152(2):231-6.
    View in: PubMed
    Score: 0.215
  10. Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm. 2006 Jun; 3(6):647-52.
    View in: PubMed
    Score: 0.209
  11. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol. 2006 Feb 15; 97(4):532-7.
    View in: PubMed
    Score: 0.207
  12. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm. 2005 Jan; 2(1):49-54.
    View in: PubMed
    Score: 0.193
  13. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol. 2004 Jul; 15(7):790-4.
    View in: PubMed
    Score: 0.186
  14. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial. Card Electrophysiol Rev. 2003 Dec; 7(4):341-4.
    View in: PubMed
    Score: 0.179
  15. Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke. Europace. 2022 07 21; 24(7):1058-1064.
    View in: PubMed
    Score: 0.163
  16. Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds. J Cardiovasc Electrophysiol. 2002 Apr; 13(4):332-5.
    View in: PubMed
    Score: 0.159
  17. Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J. 2002 Mar; 143(3):541-5.
    View in: PubMed
    Score: 0.159
  18. Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart?Failure Status. JACC Clin Electrophysiol. 2022 02; 8(2):182-193.
    View in: PubMed
    Score: 0.156
  19. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight. Am J Cardiol. 2001 Nov 01; 88(9):1043-5.
    View in: PubMed
    Score: 0.155
  20. Device-Detected Atrial Fibrillation Before and After Hospitalisation for Noncardiac Surgery or Medical Illness: Insights From ASSERT. Can J Cardiol. 2021 05; 37(5):803-809.
    View in: PubMed
    Score: 0.145
  21. Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation. J Cardiovasc Electrophysiol. 2020 12; 31(12):3166-3175.
    View in: PubMed
    Score: 0.144
  22. Active-Fixation Atrial Leads and the Risk of Atrial Fibrillation: Insights From ASSERT. Circ Arrhythm Electrophysiol. 2020 09; 13(9):e008655.
    View in: PubMed
    Score: 0.142
  23. Atrial defibrillation with a transvenous lead: a randomized comparison of active can shocking pathways. J Am Coll Cardiol. 1999 Aug; 34(2):358-62.
    View in: PubMed
    Score: 0.133
  24. The effect of shock configuration and delivered energy on defibrillation impedance. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):165-8.
    View in: PubMed
    Score: 0.127
  25. A new defibrillator discrimination algorithm utilizing electrogram morphology analysis. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):179-82.
    View in: PubMed
    Score: 0.127
  26. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). Am Heart J. 2019 05; 211:45-53.
    View in: PubMed
    Score: 0.127
  27. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk?of Heart Failure. J Am Coll Cardiol. 2018 06 12; 71(23):2603-2611.
    View in: PubMed
    Score: 0.122
  28. Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). Am Heart J. 2018 07; 201:160-163.
    View in: PubMed
    Score: 0.121
  29. Implications and treatment of atrial fibrillation after cardiothoracic surgery. Curr Opin Cardiol. 1998 Jan; 13(1):20-7.
    View in: PubMed
    Score: 0.119
  30. Induction of atrial fibrillation with low-energy defibrillator shocks in patients with implantable cardioverter defibrillators. Am J Cardiol. 1997 Oct 01; 80(7):960-2.
    View in: PubMed
    Score: 0.117
  31. Distortion of intracardiac electrograms following defibrillator shocks for atrial tachyarrhythmias. Pacing Clin Electrophysiol. 1997 Jun; 20(6):1682-5.
    View in: PubMed
    Score: 0.114
  32. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017 May 01; 38(17):1339-1344.
    View in: PubMed
    Score: 0.113
  33. Response to letter regarding article "Temporal relationship between subclinical atrial fibrillation and embolic events". Circulation. 2015 Feb 03; 131(5):e337-8.
    View in: PubMed
    Score: 0.097
  34. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014 May 27; 129(21):2094-9.
    View in: PubMed
    Score: 0.091
  35. Ethnic differences in atrial fibrillation identified using implanted cardiac devices. J Cardiovasc Electrophysiol. 2013 Apr; 24(4):381-7.
    View in: PubMed
    Score: 0.084
  36. Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. Heart Rhythm. 2012 Oct; 9(10):1667-73.
    View in: PubMed
    Score: 0.081
  37. Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial mechanisms of atrial fibrillation study. Circ Arrhythm Electrophysiol. 2012 Aug 01; 5(4):626-31.
    View in: PubMed
    Score: 0.081
  38. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12; 366(2):120-9.
    View in: PubMed
    Score: 0.079
  39. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). Am Heart J. 2006 Sep; 152(3):442-7.
    View in: PubMed
    Score: 0.054
  40. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004 Dec 15; 94(12):1572-4.
    View in: PubMed
    Score: 0.048
  41. The influence of gender on arrhythmias. Cardiol Rev. 2004 Mar-Apr; 12(2):97-105.
    View in: PubMed
    Score: 0.046
  42. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1180-6.
    View in: PubMed
    Score: 0.044
  43. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol. 2003 Aug 20; 42(4):627-33.
    View in: PubMed
    Score: 0.044
  44. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J. 2003 May; 145(5):841-6.
    View in: PubMed
    Score: 0.043
  45. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 2001 Nov; 12(11):1247-53.
    View in: PubMed
    Score: 0.039
  46. Cardiac arrhythmia: current therapy. Hosp Pract (1995). 1999 Sep 01; 34(9):27-8, 31-2, 35-8 passim.
    View in: PubMed
    Score: 0.033
  47. Reversible prolonged pacemaker failure due to electrocautery. J Interv Card Electrophysiol. 1998 Dec; 2(4):343-4.
    View in: PubMed
    Score: 0.032
  48. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol. 1997 Jul; 30(1):233-6.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.